Insights Worth Watching
What does it take to navigate today’s most complex drug development challenges? Hear expert perspectives and practical approaches that can help clarify your path forward.
Featured Video
Advancing Precision Medicine in Autoimmune Drug Development
What lessons from precision oncology can we carry forward into increasingly biomarker-driven autoimmune drug development?
Dr. Debs Phippard shares why she's excited about the varied ways biomarker and assay strategies developed for oncology can be applied to support the next generation of autoimmune therapies. As she explains, the key will be adapting those learnings to a very different immunological landscape.
Browse all videos
-
-
Watch VideoAutoimmune Disease Research in the Precision Era Part 2 - A Precision Power Couple Series
| -
Watch VideoAutoimmune Disease Research in the Precision Era Part 1 - A Precision Power Couple Series
| -
Watch VideoDose Optimization for Oncology Radiopharmaceutical Therapies | CMO Confidential
| -
-
Watch Video -
Watch Video -
Watch VideoFDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) | CMO Confidential
| -
Discover: Beyond the Data Deluge: Immune Profiling in Early Immuno-oncology Trials
Watch WebinarWebinars - Translational Research
Beyond the Data Deluge: Immune Profiling in Early Immuno-oncology Trials
| -
-
Metavate: Automated, Metadata-driven Clinical Data Transformation Engine | Product Overview
| -
-
Discover: Precision In, Precision Out: Elevated Kitting Strategies for Clinical Trials
Watch WebinarWebinars - Translational Research
Precision In, Precision Out: Elevated Kitting Strategies for Clinical Trials
| -
Watch VideoFDA Approval of Durvalumab for Muscle-Invasive Bladder Cancer | CMO Confidential
| -
AAV-based Immunogenicity Assays in Gene Therapy Development | Service Overview
| -
Discover: Future-proofing Gene Therapy Assays: Validation Strategies for Long-Term Success
Watch WebinarWebinars - Translational Research
Future-proofing Gene Therapy Assays: Validation Strategies for Long-Term Success
| -
Watch VideoFDA's Draft Guidance on Accelerated Approvals and the Impact on Biotech | CMO Confidential
| -
Discover: Gene Therapy Assays: Achieving Regulatory Compliance with a Unified Immunogenicity Strategy
Watch WebinarGene Therapy Assays: Achieving Regulatory Compliance with a Unified Immunogenicity Strategy
| -
Discover: Women As Leaders
-
Discover: Illuminating Immunohistochemistry: Right-sizing your Validation and Regulatory Strategy
Watch WebinarWebinars - Translational Research
Illuminating Immunohistochemistry: Right-sizing your Validation and Regulatory Strategy
| -
Watch Video -
Discover: Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
Watch WebinarWebinars - Translational Research
Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
| -
-
Discover: Navigating Pediatric Clinical Trials: Challenges and Specific Strategies for Success
Watch WebinarWebinars - Translational Research
Navigating Pediatric Clinical Trials: Challenges and Specific Strategies for Success
| -
Discover: Strategies for Immunogenicity Assays in AAV Gene Therapy: Development to CDx Approval
Watch WebinarWebinars - Translational Research
Strategies for Immunogenicity Assays in AAV Gene Therapy: Development to CDx Approval
| -
Discover: Companion Diagnostics: Strategies for Effective Co-Development with Therapeutics
Watch WebinarWebinars - Diagnostics and Companion Diagnostics
Companion Diagnostics: Strategies for Effective Co-Development with Therapeutics
| -
Discover: Effective Practices for Integrating Biomarkers, Biospecimens, and Science - from Concept, through Clinic, to Cloud
Watch WebinarWebinars - Translational Research
Effective Practices for Integrating Biomarkers, Biospecimens, and Science - from Concept, through Clinic, to Cloud
| -
Discover: Clinical Samples in Flow Cytometry: Best Practices for Sample Preparation and Sample Choice
Watch WebinarWebinars - Translational Research
Clinical Samples in Flow Cytometry: Best Practices for Sample Preparation and Sample Choice
| -
Discover: Incorporating Tumor Biopsy Spatial Analysis in Oncology Clinical Trials
Watch WebinarWebinars - Translational Research
Incorporating Tumor Biopsy Spatial Analysis in Oncology Clinical Trials
| -
Discover: Key Success Factors in Conducting a Translational Clinical Study
Watch WebinarWebinars - Translational Research
Key Success Factors in Conducting a Translational Clinical Study
| -
Discover: Generating Clinically Actionable Tissue Biomarker Data in Complex Diseases: Spotlight on Immuno-Oncology and Dermatology
Webinars - Translational Research
Generating Clinically Actionable Tissue Biomarker Data in Complex Diseases: Spotlight on Immuno-Oncology and Dermatology
| -
Discover: Methods to Reliably Monitor Treg Cells in Clinical Studies: Characterizing a Central Switch of Immune Suppression
Watch WebinarWebinars - Translational Research
Methods to Reliably Monitor Treg Cells in Clinical Studies: Characterizing a Central Switch of Immune Suppression
| -
Discover: Flow Cytometry for Clinical Applications: Recommendations on Assay Transfer and Method Validation
Watch WebinarWebinars - Translational Research
Flow Cytometry for Clinical Applications: Recommendations on Assay Transfer and Method Validation
| -
Discover: Bridging the Preclinical to Clinical Divide: Practical Considerations for Biomarker Success
Watch WebinarWebinars - Translational Research
Bridging the Preclinical to Clinical Divide: Practical Considerations for Biomarker Success
| -
Discover: NAb vs TAb Assays in Gene Therapy Development: Key Considerations for Assessing Immunogenicity
Watch WebinarWebinars - Translational Research
NAb vs TAb Assays in Gene Therapy Development: Key Considerations for Assessing Immunogenicity
| -
Discover: Effective Methods for Immune Monitoring in Autoimmune Trials
-
Discover: Next Generation Immune Monitoring in Immune-Oncology Clinical Trials
Webinars - Translational Research
Next Generation Immune Monitoring in Immune-Oncology Clinical Trials
|
Nothing Yet...
Meet Our Experts
With a deep and diverse bench of subject matter experts, the Precision team is committed to sharing specialty knowledge and real-world learnings to help sponsors navigate scientific, clinical, and operational complexities at every stage of drug development.
-
Harpreet Singh, MD
-
Deborah Phippard, PhD
-
Nick Richardson, DO, MPH
-
Kennon Daniels, PhD
-
Simon Fleming
-
Maham Ansari
Harpreet Singh, MD
Chief Medical Officer
Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.
Deborah Phippard, PhD
Chief Scientific Officer
Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
Nick Richardson, DO, MPH
Vice President, Clinical Development
An expert in hematology and oncology and a veteran of the FDA with almost nine years of experience, culminating as a Deputy Director for the Division of Hematologic Malignancies 2. Possesses a profound understanding of regulatory strategy, particularly in the development of CAR-T cell therapies, bispecifics and T-cell engagers. Spearheaded initiatives to develop novel endpoints in blood cancer such as minimal residual disease (MRD) in lymphoma and chronic lymphocytic leukemia (CLL.)
Kennon Daniels, PhD
Vice President, IVD Regulatory Consulting
Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms.
Simon Fleming
Executive Vice President
Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.
Maham Ansari
Senior Director, IVD Regulatory Affairs, Gene Therapy CDx
Maham Ansari, MS, RAC is a Senior Director, IVD Regulatory Affairs. Her focus is on companion diagnostic co-development programs, where she leverages her regulatory expertise to secure approvals in the US, Europe and beyond for companion diagnostics with a specific focus on gene therapy. She brings more than 16 years of global regulatory leadership experience in the medical device and in vitro diagnostics industry, spanning major multinationals to small start-ups, including full life cycle management across all stages of product development, execution of global regulatory strategies, and post-market surveillance.